The Discounted Cash Flow (DCF) valuation of Blueprint Medicines Corp (BPMC) is (301.68) USD. With the latest stock price at 112.19 USD, the upside of Blueprint Medicines Corp based on DCF is -368.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.3% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (797.88) - (191.33) | (301.68) |
| Upside | -811.2% - -270.5% | -368.9% |